- Home
- STK vs CYRX Comparison
STK vs CYRX Comparison
Compare STK & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STK
- CYRX
- Stock Information
- Founded
- STK 2009
- CYRX 1999
- Country
- STK United States
- CYRX United States
- Employees
- STK N/A
- CYRX N/A
- Industry
- STK Investment Managers
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- STK Finance
- CYRX Health Care
- Exchange
- STK Nasdaq
- CYRX Nasdaq
- Market Cap
- STK 511.3M
- CYRX 438.7M
- IPO Year
- STK N/A
- CYRX N/A
- Fundamental
- Price
- STK $34.69
- CYRX $10.05
- Analyst Decision
- STK
- CYRX Strong Buy
- Analyst Count
- STK 0
- CYRX 10
- Target Price
- STK N/A
- CYRX $12.20
- AVG Volume (30 Days)
- STK 38.2K
- CYRX 611.4K
- Earning Date
- STK 01-01-0001
- CYRX 11-06-2025
- Dividend Yield
- STK 6.60%
- CYRX N/A
- EPS Growth
- STK N/A
- CYRX N/A
- EPS
- STK N/A
- CYRX 1.35
- Revenue
- STK N/A
- CYRX $237,879,000.00
- Revenue This Year
- STK N/A
- CYRX N/A
- Revenue Next Year
- STK N/A
- CYRX $9.09
- P/E Ratio
- STK N/A
- CYRX $7.41
- Revenue Growth
- STK N/A
- CYRX 24.93
- 52 Week Low
- STK $24.95
- CYRX $4.58
- 52 Week High
- STK $34.31
- CYRX $10.46
- Technical
- Relative Strength Index (RSI)
- STK 82.02
- CYRX 61.75
- Support Level
- STK $31.07
- CYRX $8.53
- Resistance Level
- STK $32.75
- CYRX $10.46
- Average True Range (ATR)
- STK 0.32
- CYRX 0.62
- MACD
- STK 0.23
- CYRX -0.03
- Stochastic Oscillator
- STK 95.67
- CYRX 82.40
About STK Columbia Seligman Premium Technology Growth Fund Inc
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.